Matches in SemOpenAlex for { <https://semopenalex.org/work/W3081730907> ?p ?o ?g. }
- W3081730907 endingPage "59" @default.
- W3081730907 startingPage "53" @default.
- W3081730907 abstract "BackgroundPharmacovigilance is a critical component to facilitate clinicians’ decision-making to alter or discontinue therapy. However, self-administration of oral targeted therapy (OTT) requires fewer clinical visits than parenteral infusions, potentially leading to an increase in the under-reporting of adverse drug reactions (ADRs).Objective(s)To identify factors associated with patients reporting ADRs to their health care provider (HCP) and to identify the prevalence of unreported ADRs while on OTT.MethodsPatients aged ≥18 years who received care from a community oncology clinic and newly prescribed an OTT between August 1, 2018, and October 31, 2018, were included. Six-monthly follow-up calls were conducted by the pharmacy staff to assess for gradable ADRs—validated by the NCI Common Terminology Criteria for Adverse Events—and ungradable ADRs. Descriptive analysis was used to analyze the prevalence of unreporting ADRs, and a multivariate logistic regression model was utilized to evaluate predictors of reporting ADRs to an HCP. Predictors included sociodemographic factors, severity of ADRs, insurance type, pharmacy setting, type of OTT, and the number of prescribed medicationsResultsOf the 76 patients analyzed, the mean age was 63.32 ±11.55 years, 84.2% were women, 68.8% were non-Hispanic white, and 76.3% had breast cancer. During the follow-up calls, 306 ADRs were identified and 22.2% were not previously reported to an HCP. Of the unreported gradable ADRs, 63.2% were grade 1, 19.3% were grade 2, and 17.5% were grade 3. We found that for every 1-year increase in age, there was a 5% decrease in the likelihood of reporting ADRs (95% CI, 0.91–0.99), and men were 11.4 times more likely to report ADRs (95% CI, 1.29–100.8).ConclusionFollow-up calls served as an outlet to collect pharmacovigilance data by identifying over 20% of unreported ADRs to HCPs, in which over one-third were moderate to severe. However, future studies are needed to further understand the statistically significant differences found in under-reporting for women and the older population." @default.
- W3081730907 created "2020-09-08" @default.
- W3081730907 creator A5010585334 @default.
- W3081730907 creator A5040180882 @default.
- W3081730907 creator A5078289225 @default.
- W3081730907 creator A5082729434 @default.
- W3081730907 date "2021-01-01" @default.
- W3081730907 modified "2023-09-30" @default.
- W3081730907 title "Prevalence and predictors of patients reporting adverse drug reactions to health care providers during oral targeted cancer treatment" @default.
- W3081730907 cites W1556283989 @default.
- W3081730907 cites W1921849213 @default.
- W3081730907 cites W1971584973 @default.
- W3081730907 cites W1983149471 @default.
- W3081730907 cites W2036051294 @default.
- W3081730907 cites W2042132720 @default.
- W3081730907 cites W2050104081 @default.
- W3081730907 cites W2088635995 @default.
- W3081730907 cites W2091918360 @default.
- W3081730907 cites W2091977915 @default.
- W3081730907 cites W2114574065 @default.
- W3081730907 cites W2159091303 @default.
- W3081730907 cites W2210004604 @default.
- W3081730907 cites W2264125489 @default.
- W3081730907 cites W2560571493 @default.
- W3081730907 cites W2568798765 @default.
- W3081730907 cites W2598266589 @default.
- W3081730907 cites W2614613518 @default.
- W3081730907 cites W2620925856 @default.
- W3081730907 cites W2704172323 @default.
- W3081730907 cites W2804880019 @default.
- W3081730907 cites W2883759047 @default.
- W3081730907 cites W2886769216 @default.
- W3081730907 cites W2935014396 @default.
- W3081730907 cites W3081024796 @default.
- W3081730907 doi "https://doi.org/10.1016/j.japh.2020.09.001" @default.
- W3081730907 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33032945" @default.
- W3081730907 hasPublicationYear "2021" @default.
- W3081730907 type Work @default.
- W3081730907 sameAs 3081730907 @default.
- W3081730907 citedByCount "4" @default.
- W3081730907 countsByYear W30817309072022 @default.
- W3081730907 countsByYear W30817309072023 @default.
- W3081730907 crossrefType "journal-article" @default.
- W3081730907 hasAuthorship W3081730907A5010585334 @default.
- W3081730907 hasAuthorship W3081730907A5040180882 @default.
- W3081730907 hasAuthorship W3081730907A5078289225 @default.
- W3081730907 hasAuthorship W3081730907A5082729434 @default.
- W3081730907 hasBestOaLocation W30817309071 @default.
- W3081730907 hasConcept C104863432 @default.
- W3081730907 hasConcept C118552586 @default.
- W3081730907 hasConcept C126322002 @default.
- W3081730907 hasConcept C151956035 @default.
- W3081730907 hasConcept C159110408 @default.
- W3081730907 hasConcept C160735492 @default.
- W3081730907 hasConcept C162324750 @default.
- W3081730907 hasConcept C194828623 @default.
- W3081730907 hasConcept C197934379 @default.
- W3081730907 hasConcept C2426938 @default.
- W3081730907 hasConcept C2780035454 @default.
- W3081730907 hasConcept C2993432071 @default.
- W3081730907 hasConcept C38180746 @default.
- W3081730907 hasConcept C50522688 @default.
- W3081730907 hasConcept C512399662 @default.
- W3081730907 hasConcept C71924100 @default.
- W3081730907 hasConceptScore W3081730907C104863432 @default.
- W3081730907 hasConceptScore W3081730907C118552586 @default.
- W3081730907 hasConceptScore W3081730907C126322002 @default.
- W3081730907 hasConceptScore W3081730907C151956035 @default.
- W3081730907 hasConceptScore W3081730907C159110408 @default.
- W3081730907 hasConceptScore W3081730907C160735492 @default.
- W3081730907 hasConceptScore W3081730907C162324750 @default.
- W3081730907 hasConceptScore W3081730907C194828623 @default.
- W3081730907 hasConceptScore W3081730907C197934379 @default.
- W3081730907 hasConceptScore W3081730907C2426938 @default.
- W3081730907 hasConceptScore W3081730907C2780035454 @default.
- W3081730907 hasConceptScore W3081730907C2993432071 @default.
- W3081730907 hasConceptScore W3081730907C38180746 @default.
- W3081730907 hasConceptScore W3081730907C50522688 @default.
- W3081730907 hasConceptScore W3081730907C512399662 @default.
- W3081730907 hasConceptScore W3081730907C71924100 @default.
- W3081730907 hasIssue "1" @default.
- W3081730907 hasLocation W30817309071 @default.
- W3081730907 hasOpenAccess W3081730907 @default.
- W3081730907 hasPrimaryLocation W30817309071 @default.
- W3081730907 hasRelatedWork W1792828491 @default.
- W3081730907 hasRelatedWork W1984922927 @default.
- W3081730907 hasRelatedWork W2002144859 @default.
- W3081730907 hasRelatedWork W2100202205 @default.
- W3081730907 hasRelatedWork W2117119099 @default.
- W3081730907 hasRelatedWork W2129770550 @default.
- W3081730907 hasRelatedWork W2386202886 @default.
- W3081730907 hasRelatedWork W2413601699 @default.
- W3081730907 hasRelatedWork W2802859181 @default.
- W3081730907 hasRelatedWork W4225285109 @default.
- W3081730907 hasVolume "61" @default.
- W3081730907 isParatext "false" @default.
- W3081730907 isRetracted "false" @default.
- W3081730907 magId "3081730907" @default.